StocksFin Logo
IMPL logo
$IMPL

Impel Pharmaceuticals Inc.

IMPL country of incorporation
|
https://impelpharma.com
|
Mr. Adrian Adams
|
129 employees
NASDAQ | Healthcare | Biotechnology
IMPL reported its Q322 earnings on November 14, 2022 (103 weeks ago).
$3.08M 3386713.2% vs. Q321 Revenues Q322
51.07% 129.2% vs. Q321 Gross Profit Margin
-1000% ! 0% vs. Q321 Net Profit Margin
-47.05M ! -170.8% vs. Q321 Free Cash Flow Q322
$-1.31 ! -50284.6% vs. Q321 EPS Q322
Company Card Q322
As reported on November 14, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 14, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
3.08M
+10%
1.51M
-31.1M
-23.4%
$-1.31
Q22022
2.8M
+59.4%
1.74M
-25.2M
+6.5%
$-1.09
Q12022
1.76M
1.03M
-26.97M
$-1.17
FY2021
668k
 691k
-76.67M
$-5.25
Q42021
668
-100%
691
-49.84k
+3.8%
$-0
Q32021
91
+10%
250
-51.79k
+99.7%
$-0
Q22021
0
+59.4%
0
-15.48M
-37.1%
$-1.1
Q12021
0
0
-11.29M
$-0.59
FY2020
0
 0
-45.8M
$-3.47
FY2019
0
 0
-41.86M
$-3.22
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
105.17M
 127.46M
79.73M
50.29M
-22.29M
Q22022
120.43M
 116.52M
97.83M
50.27M
3.91M
Q12022
147.8M
 120.32M
129.84M
49.7M
27.48M
FY2021
97.91M
 45.4M
88.21M
29.45M
52.51M
FY2020
12.06M
 145.56M
7.1M
8.83M
-133.5M
FY2019
42.27M
 133.97M
37M
0
-91.7M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-46.89M
 -158k
70.58M
-158k
-47.05M
-62.4%
Q22022
-28.77M
 -207k
-3.04M
-207k
-28.97M
-19.6%
Q12022
-24.21M
 -8k
65.84M
-8k
-24.22M
FY2021
-66.36M
 -408k
147.89M
-408k
-66.77M
FY2020
-39.18M
 -1.78M
11.06M
-1.78M
-40.97M
FY2019 No data.
Institutional Ownership
Dividend History
No dividend history.
Number of Employees